<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194817/" ref="ordinalpos=2311&amp;ncbi_uid=3296728&amp;link_uid=PMC3194817" image-link="/pmc/articles/PMC3194817/figure/pone-0025847-g009/" class="imagepopup">Figure 9. Wnt <span class="highlight" style="background-color:">signaling</span> inhibition “rescues” GSK-3β null embryo osteogenic gene expression and Hedgehog <span class="highlight" style="background-color:">signaling</span> activity..  From: Role of GSK-3β in the Osteogenic Differentiation of Palatal Mesenchyme. </a></div><br /><div class="p4l_captionBody">(A–B) e13.5 GSK-3β +/+ and −/− embryo palate cultures treated for 2 days with DMEM F12 +/− supplementation with Dkk-1 (100 ng/mL). (A) qRT-PCR for the osteogenic gene markers Alp, Runx2, Ocn, and Col1a1. N = 3, *&lt;0.01. (B) qRT-PCR for members of the Hedgehog signaling pathway (Ihh, Shh, Ptch1, and Gli1). N = 3, *&lt;0.01.</div></div>